The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Non-alcoholic fatty liver disease pathogenesis: The present and the future
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R., & Lechler, R. I. (1998) · Nature · doi:10.1038/29795 · Cited by 2,160
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
Hypovitaminosis D is associated with insulin resistance and β cell dysfunction
Chiu, K. C., Chu, A., Go, V. L. W., & Saad, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.820 · Cited by 1,642
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker, J., Hui, J. M., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30692 · Cited by 1,122
Osei-Hyiaman, D., DePetrillo, M., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523057 · Cited by 1,101
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
Liver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, E., Thibault, V., Theodorou, I., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 973
Reddy, J. K., & Hashimoto, T. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.193 · Cited by 959
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., DeSimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930
Biologically active products of stimulated liver macrophages (Kupffer cells)
DECKER, K. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19222.x · Cited by 904
The endocrine function of adipose tissue: an update
Ronti, T., Lupattelli, G., & Mannarino, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02474.x · Cited by 902
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Unger, R. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104057 · Cited by 875
Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., & Gonzalez, F. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5678 · Cited by 863
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854 · cited 2×
“The interaction of insulin with its tetrameric receptor stimlates autophosphorylation of tyrosine residues that promote he Janus-activated kinases (JAK) and insulin receptor substrates IRS)-1 and IRS-2 activation [80,81].”
BackgroundFeldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 834
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes
Wolf, A. M., Wolf, D., Rumpold, H., Enrich, B., & Tilg, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.145 · Cited by 819
Platelet-Derived Serotonin Mediates Liver Regeneration
Lesurtel, M., Graf, R., Aleil, B., Walther, D. J., Tian, Y., Jochum, W., Gachet, C., Bader, M., & Clavien, P.-A. (2006) · Science · doi:10.1126/science.1123842 · Cited by 788
Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734
Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis
Malhi, H., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510660200 · Cited by 722
Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300043200 · Cited by 707
Rivera, C. A., Adegboyega, P., van Rooijen, N., Tagalicud, A., Allman, M., & Wallace, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.019 · Cited by 693
Crespo, J., Cayón, A., Fernández-Gil, P., Hernández-Guerra, M., Mayorga, M., Domínguez-Díez, A., Fernández-Escalante, J. C., & Pons-Romero, F. (2001) · Hepatology · doi:10.1053/jhep.2001.29628 · Cited by 693
Antibiotics prevent liver injury in rats following long-term exposure to ethanol
Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W., & Thurman, R. G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90027-6 · Cited by 692
Bugianesi, E., Gentilcore, E., Manini, R., Natale, S., Vanni, E., Villanova, N., David, E., Rizzetto, M., & Marchesini, G. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41583.x · Cited by 691
Ueki, K., Kondo, T., & Kahn, C. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5434-5446.2004 · Cited by 686
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
MUSSO, G., GAMBINO, R., & CASSADER, M. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.08.001 · Cited by 681
Wieckowska, A., Zein, N. N., Yerian, L. M., Lopez, R. A., McCullough, A. J., & Feldstein, A. E. (2006) · Hepatology · doi:10.1002/hep.21223 · Cited by 670
Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults
Ford, E. S., Ajani, U. A., McGuire, L. C., & Liu, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1228 · Cited by 666
Oxygen, Reactive Oxygen Species and Tissue Damage
Bergamini, C., Gambetti, S., Dondi, A., & Cervellati, C. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384664 · Cited by 661
Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.038 · Cited by 631
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
Ueno, T., Sugawara, H., Sujaku, K., Hashimoto, O., Tsuji, R., Tamaki, S., Torimura, T., Inuzuka, S., Sata, M., & Tanikawa, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80287-5 · Cited by 609
Visceral fat: A key mediator of steatohepatitis in metabolic liver disease†
van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M. I., Kench, J. G., London, R., Peduto, T., Chisholm, D. J., & George, J. (2008) · Hepatology · doi:10.1002/hep.22350 · Cited by 607
Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
Zhou, J., Febbraio, M., Wada, T., Zhai, Y., Kuruba, R., He, J., Lee, J. H., Khadem, S., Ren, S., Li, S., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.037 · Cited by 605
Haukeland, J. W., Damås, J. K., Konopski, Z., Løberg, E. M., Haaland, T., Goverud, I., Torjesen, P. A., Birkeland, K., Bjøro, K., & Aukrust, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.02.011 · Cited by 603
Matsusue, K., Haluzik, M., Lambert, G., Yim, S.-H., Gavrilova, O., Ward, J. M., Brewer, B., Reitman, M. L., & Gonzalez, F. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317223 · Cited by 585
The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence
Mantzoros, C. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-8-199904200-00014 · Cited by 584
Paradis, V., Perlemuter, G., Bonvoust, F., Dargere, D., Parfait, B., Vidaud, M., Conti, M., Huet, S., Ba, N., Buffet, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.28055 · Cited by 542
Matarese, G., Moschos, S., & Mantzoros, C. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3137 · Cited by 537
Wang, D., Wei, Y., & Pagliassotti, M. J. (2006) · Endocrinology · doi:10.1210/en.2005-0570 · Cited by 529
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Teixeira-Clerc, F., Julien, B., Grenard, P., Van Nhieu, J. T., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 528
Pharmacology of Cannabinoid Receptor Ligands
Pertwee, R. G. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401124036 · Cited by 526
Human Leptin Enhances Activation and Proliferation of Human Circulating T Lymphocytes
Martín-Romero, C., Santos-Alvarez, J., Goberna, R., & Sánchez-Margalet, V. (2000) · Cellular Immunology · doi:10.1006/cimm.1999.1594 · Cited by 524
The nuclear receptor LXR is a glucose sensor
Mitro, N., Mak, P. A., Vargas, L., Godio, C., Hampton, E., Molteni, V., Kreusch, A., & Saez, E. (2007) · Nature · doi:10.1038/nature05449 · Cited by 524
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin
Bergheim, I., Weber, S., Vos, M., Krämer, S., Volynets, V., Kaserouni, S., McClain, C. J., & Bischoff, S. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.035 · Cited by 522
Seki, S., Kitada, T., Yamada, T., Sakaguchi, H., Nakatani, K., & Wakasa, K. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00073-9 · Cited by 521
Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E
Kugelmas, M., Hill, D. B., Vivian, B., Marsano, L., & McClain, C. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50316 · Cited by 504
Central Role of Pparα–Dependent Hepatic Lipid Turnover in Dietary Steatohepatitis in Mice
Ip, E., Farrell, G. C., Robertson, G., Hall, P., Kirsch, R., & Leclercq, I. (2003) · Hepatology · doi:10.1053/jhep.2003.50307 · Cited by 476
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
Julien, B., Grenard, P., Teixeira-Clerc, F., Van Nhieu, J. T., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470
Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
Fassio, E., �lvarez, E., Dom�nguez, N., Landeira, G., & Longo, C. (2004) · Hepatology · doi:10.1002/hep.20410 · Cited by 469
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases
Loguercio, C., Federico, A., Tuccillo, C., Terracciano, F., D'Auria, M. V., De Simone, C., & Blanco, C. D. V. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000165671.25272.0f · Cited by 449
Peroxisome proliferator activated receptor-alpha expression in human liver.
Palmer, C. N., Hsu, M. H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · PubMed · Cited by 448
Targher, G., Bertolini, L., Scala, L., Cigolini, M., Zenari, L., Falezza, G., & Arcaro, G. (2007) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.04.002 · Cited by 440
Tomita, K., Tamiya, G., Ando, S., Ohsumi, K., Chiyo, T., Mizutani, A., Kitamura, N., Toda, K., Kaneko, T., Horie, Y., et al. (2006) · Gut · doi:10.1136/gut.2005.071118 · Cited by 438
Lactobacillus Feeding Reduces Endotoxemia and Severity of Experimental Alcoholic Liver (Disease)
Nanji, A. A., Khettry, U., & Sadrzadeh, S. M. H. (1994) · Experimental Biology and Medicine · doi:10.3181/00379727-205-43703 · Cited by 436
Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice
Dentin, R., Benhamed, F., Hainault, I., Fauveau, V., Foufelle, F., Dyck, J. R. B., Girard, J., & Postic, C. (2006) · Diabetes · doi:10.2337/db06-0200 · Cited by 433
The metabolic syndrome: requiescat in pace
Reaven, G. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.048611 · Cited by 427
Model of nonalcoholic steatohepatitis
Lieber, C. S., Leo, M. A., Mak, K. M., Xu, Y., Cao, Q., Ren, C., Ponomarenko, A., & DeCarli, L. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.502 · Cited by 424
The endocannabinoid system as a target for therapeutic drugs
Piomelli, D., Giuffrida, A., Calignano, A., & Rodrı́guez de Fonseca, F. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01482-6 · Cited by 421
Reddy, J. K., & Mannaerts, G. P. (1994) · Annual Review of Nutrition · doi:10.1146/annurev.nu.14.070194.002015 · Cited by 417
Peroxisome Proliferator Activated Receptor-α Expression in Human Liver
Palmer, C. N. A., Hsu, M.-H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.14 · Cited by 416
Adiponectin and its receptors in non-alcoholic steatohepatitis
Kaser, S., Moschen, A., Cayon, A., Kaser, A., Crespo, J., Pons-Romero, F., Ebenbichler, C. F., Patsch, J. R., & Tilg, H. (2005) · Gut · doi:10.1136/gut.2003.037010 · Cited by 412
Bugianesi, E., Pagotto, U., Manini, R., Vanni, E., Gastaldelli, A., de Iasio, R., Gentilcore, E., Natale, S., Cassader, M., Rizzetto, M., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2240 · Cited by 408
Klöting, N., Graham, T. E., Berndt, J., Kralisch, S., Kovacs, P., Wason, C. J., Fasshauer, M., Schön, M. R., Stumvoll, M., Blüher, M., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.002 · Cited by 406
Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
Masaki, T., Chiba, S., Tatsukawa, H., Yasuda, T., Noguchi, H., Seike, M., & Yoshimatsu, H. (2004) · Hepatology · doi:10.1002/hep.20282 · Cited by 402
Toll-Like Receptor Signaling in the Liver
Schwabe, R. F., Seki, E., & Brenner, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.038 · Cited by 401
Day, C. P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.017 · Cited by 395
Schoonjans, K., Watanabe, M., Suzuki, H., Mahfoudi, A., Krey, G., Wahli, W., Grimaldi, P., Staels, B., Yamamoto, T., & Auwerx, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19269 · Cited by 395
Ueki, K., Kondo, T., Tseng, Y.-H., & Kahn, C. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402511101 · Cited by 384
Nonalcoholic Fatty Liver Disease: Cytokine-Adipokine Interplay and Regulation of Insulin Resistance
Tilg, H., & Hotamisligil, G. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.054 · Cited by 384
Tetri, L. H., Basaranoglu, M., Brunt, E. M., Yerian, L. M., & Neuschwander-Tetri, B. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90272.2008 · Cited by 378
Effect of weight reduction on hepatic abnormalities in overweight patients
Palmer, M., & Schaffner, F. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91169-7 · Cited by 374
Attenuation of leptin and insulin signaling by SOCS proteins
Howard, J. K., & Flier, J. S. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.09.007 · Cited by 370
Yahagi, N., Shimano, H., Hasty, A. H., Matsuzaka, T., Ide, T., Yoshikawa, T., Amemiya-Kudo, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201584200 · Cited by 370
Mitochondrial Adaptations to Obesity-Related Oxidant Stress
Yang, S., Zhu, H., Li, Y., Lin, H., Gabrielson, K., Trush, M. A., & Diehl, A. M. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1829 · Cited by 368
Boucher, B. J., Mannan, N., Noonan, K., Hales, C. N., & Evans, S. J. W. (1995) · Diabetologia · doi:10.1007/bf00422375 · Cited by 365
Chitturi, S., Farrell, G., Frost, L., Kriketos, A., Lin, R., Liddle, C., Samarasinghe, D., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.34738 · Cited by 362
Production and physiological actions of anandamide in the vasculature of the rat kidney.
Deutsch, D. G., Goligorsky, M. S., Schmid, P. C., Krebsbach, R. J., Schmid, H. H., Das, S. K., Dey, S. K., Arreaza, G., Thorup, C., Stefano, G., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119677 · Cited by 360
Chao, L., Marcus-Samuels, B., Mason, M. M., Moitra, J., Vinson, C., Arioglu, E., Gavrilova, O., & Reitman, M. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11245 · Cited by 356
Retinol-Binding Protein 4 in Human Obesity
Janke, J., Engeli, S., Boschmann, M., Adams, F., Böhnke, J., Luft, F. C., Sharma, A. M., & Jordan, J. (2006) · Diabetes · doi:10.2337/db06-0616 · Cited by 352
Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause
Taylor, R. (2008) · Diabetologia · doi:10.1007/s00125-008-1116-7 · Cited by 352
Chalasani, N., Deeg, M. A., & Crabb, D. W. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30159.x · Cited by 343
Gao, Z., Zhang, X., Zuberi, A., Hwang, D., Quon, M. J., Lefevre, M., & Ye, J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0383 · Cited by 335
Svegliati-Baroni, G., Ridolfi, F., Di Sario, A., Casini, A., Marucci, L., Gaggiotti, G., Orlandoni, P., Macarri, G., Perego, L., Benedetti, A., et al. (1999) · Hepatology · doi:10.1002/hep.510290632 · Cited by 320
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice
Feldstein, A. E., Canbay, A., Guicciardi, M. E., Higuchi, H., Bronk, S. F., & Gores, G. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00460-4 · Cited by 320
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease
Suzuki, A., Lindor, K., Saver, J. S., Lymp, J., Mendes, F., Muto, A., Okada, T., & Angulo, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.008 · Cited by 319
A high‐fat diet leads to the progression of non‐alcoholic fatty liver disease in obese rats
Carmiel-Haggai, M., Cederbaum, A. I., & Nieto, N. (2005) · The FASEB Journal · doi:10.1096/fj.04-2291fje · Cited by 318
Thomas, E. L., Hamilton, G., Patel, N., O’Dwyer, R., Doré, C. J., Goldin, R. D., Bell, J. D., & Taylor-Robinson, S. D. (2005) · Gut · doi:10.1136/gut.2003.036566 · Cited by 317
Gary-Bobo, M., Elachouri, G., Gallas, J. F., Janiak, P., Marini, P., Ravinet-Trillou, C., Chabbert, M., Cruccioli, N., Pfersdorff, C., Roque, C., et al. (2007) · Hepatology · doi:10.1002/hep.21641 · Cited by 304
Daily Cannabis Smoking as a Risk Factor for Progression of Fibrosis in Chronic Hepatitis C *
Hézode, C., Roudot-Thoraval, F., Nguyen, S., Grenard, P., Julien, B., Zafrani, E.-S., Pawlostky, J.-M., Dhumeaux, D., Lotersztajn, S., & Mallat, A. (2005) · Hepatology · doi:10.1002/hep.20733 · Cited by 293
Sahai, A., Malladi, P., Pan, X., Paul, R., Melin-Aldana, H., Green, R. M., & Whitington, P. F. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00199.2004 · Cited by 290
Yesilova, Z., Yaman, H., Oktenli, C., Ozcan, A., Uygun, A., Cakir, E., Sanisoglu, S. Y., Erdil, A., Ates, Y., Aslan, M., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41500.x · Cited by 289
Ikejima, K., Honda, H., Yoshikawa, M., Hirose, M., Kitamura, T., Takei, Y., & Sato, N. (2001) · Hepatology · doi:10.1053/jhep.2001.26518 · Cited by 288
Solinas, G., Naugler, W., Galimi, F., Lee, M.-S., & Karin, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607626103 · Cited by 284
Pirola, L., Johnston, A. M., & Van Obberghen, E. (2004) · Diabetologia · doi:10.1007/s00125-003-1313-3 · Cited by 283
Interleukin-6 depletion selectively improves hepatic insulin action in obesity.
Klover, P. J., Clementi, A. H., & Mooney, R. A. (2005) · Endocrinology · doi:10.1210/en.2004-1468 · Cited by 273
Adipokines in NASH: Postprandial Lipid Metabolism as a Link Between Adiponectin and Liver Disease *
Musso, G., Gambino, R., Durazzo, M., Biroli, G., Carello, M., Fagà, E., Pacini, G., De Michieli, F., Rabbione, L., Premoli, A., et al. (2005) · Hepatology · doi:10.1002/hep.20896 · Cited by 271
Adiponectin and resistin--new hormones of white adipose tissue.
Bełtowski, J. (2003) · PubMed · Cited by 268
Dietary habits and nutrient intake in non-alcoholic steatohepatitis
Toshimitsu, K., Matsuura, B., Ohkubo, I., Niiya, T., Furukawa, S., Hiasa, Y., Kawamura, M., Ebihara, K., & Onji, M. (2007) · Nutrition · doi:10.1016/j.nut.2006.09.004 · Cited by 264
Kakuma, T., Lee, Y., Higa, M., Wang, Z.-W., Pan, W., Shimomura, I., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8536 · Cited by 261
Serum leptin levels in patients with nonalcoholic steatohepatitis
Uygun, A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02090-6 · Cited by 256
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
Adams, L. A., Feldstein, A., Lindor, K. D., & Angulo, P. (2004) · Hepatology · doi:10.1002/hep.20140 · Cited by 252
Sabaté, J.-M., Jouët, P., Harnois, F., Mechler, C., Msika, S., Grossin, M., & Coffin, B. (2008) · Obesity Surgery · doi:10.1007/s11695-007-9398-2 · Cited by 251
Hypertension, Angiotensin II, and Oxidative Stress
Sowers, J. R. (2002) · New England Journal of Medicine · doi:10.1056/nejme020054 · Cited by 242
A Pilot Trial of Pentoxifylline in Nonalcoholic Steatohepatitis
Adams, L. A., Zein, C. O., Angulo, P., & Lindor, K. D. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40064.x · Cited by 234
Namikawa, C., Shu-Ping, Z., Vyselaar, J. R., Nozaki, Y., Nemoto, Y., Ono, M., Akisawa, N., Saibara, T., Hiroi, M., Enzan, H., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.028 · Cited by 234
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis
Hirose, A., Ono, M., Saibara, T., Nozaki, Y., Masuda, K., Yoshioka, A., Takahashi, M., Akisawa, N., Iwasaki, S., Oben, J. A., et al. (2007) · Hepatology · doi:10.1002/hep.21638 · Cited by 232
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy†
Javor, E. D., Ghany, M. G., Cochran, E. K., Oral, E. A., DePaoli, A. M., Premkumar, A., Kleiner, D. E., & Gorden, P. (2005) · Hepatology · doi:10.1002/hep.20672 · Cited by 228 · cited 3×
“compared to controls [118,137]”
BackgroundOxidative-stress and IL-6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells
Nieto, N. (2006) · Hepatology · doi:10.1002/hep.21427 · Cited by 227
Drenick, E. J., Fisler, J., & Johnson, D. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80403-4 · Cited by 226
The Roles of Leptin and Adiponectin
Ding, X., Saxena, N. K., Lin, S., Xu, A., Srinivasan, S., & Anania, F. A. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62476-5 · Cited by 225
The Effect of a Low-Carbohydrate, Ketogenic Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study
Tendler, D., Lin, S., Yancy, W. S., Mavropoulos, J., Sylvestre, P., Rockey, D. C., & Westman, E. C. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9433-5 · Cited by 220
Pharmacological actions and therapeutic uses of cannabis and cannabinoids
Kumar, R. N., Chambers, W. A., & Pertwee, R. G. (2001) · Anaesthesia · doi:10.1046/j.1365-2044.2001.02269.x · Cited by 218
Sumida, Y., Nakashima, T., Yoh, T., Furutani, M., Hirohama, A., Kakisaka, Y., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., Okanoue, T., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00331-8 · Cited by 215
Steatohepatitis Induced by Intragastric Overfeeding in Mice *
Deng, Q.-G., She, H., Cheng, J. H., French, S. W., Koop, D. R., Xiong, S., & Tsukamoto, H. (2005) · Hepatology · doi:10.1002/hep.20877 · Cited by 215
Serotonin Regulates Osteoclast Differentiation Through Its Transporter
Battaglino, R., Fu, J., Späte, U., Ersoy, U., Joe, M., Sedaghat, L., & Stashenko, P. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040606 · Cited by 213
Stefan, N., Hennige, A. M., Staiger, H., Machann, J., Schick, F., Schleicher, E., Fritsche, A., & Häring, H.-U. (2007) · Diabetes Care · doi:10.2337/dc06-2342 · Cited by 213
Nair, S. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02265-1 · Cited by 212
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
Lin, H.-Y., Yu, I.-C., Wang, R.-S., Chen, Y.-T., Liu, N.-C., Altuwaijri, S., Hsu, C.-L., Ma, W.-L., Jokinen, J., Sparks, J. D., et al. (2008) · Hepatology · doi:10.1002/hep.22252 · Cited by 209
Apoptosis in alcoholic and nonalcoholic steatohepatitis
Feldstein, A. (2005) · Frontiers in Bioscience · doi:10.2741/1765 · Cited by 203
Interleukin 6 Is Important for Survival After Partial Hepatectomy in Mice
Blindenbacher, A., Wang, X., Langer, I., Savino, R., Terracciano, L., & Heim, M. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50378 · Cited by 202 · cited 3×
“uman models of IR and NAFLD [122,134–140], and human studies ave founda linear relationshipbetweenbothserumandhepatic ILoliferator-activated receptor ; ROS, reactive oxygen species; SOCS, suppressor of”
BackgroundHolden, P., & Tugwood, J. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220001 · Cited by 201
Kechagias, S., Ernersson, Å., Dahlqvist, O., Lundberg, P., Lindström, T., Nystrom, F. H., & for the Fast Food Study Group (2008) · Gut · doi:10.1136/gut.2007.131797 · Cited by 201
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease
Angulo, P., Alba, L. M., Petrovic, L. M., Adams, L. A., Lindor, K. D., & Jensen, M. D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.020 · Cited by 197
The Modulation of Inflammatory Gene Expression by Lipids: Mediation through Toll-like Receptors
Lee, J. Y., & Hwang, D. H. (2006) · Molecules and Cells · doi:10.1016/s1016-8478(23)12877-9 · Cited by 196
The Kruppel-Like Factor 6 Genotype Is Associated With Fibrosis in Nonalcoholic Fatty Liver Disease
Miele, L., Beale, G., Patman, G., Nobili, V., Leathart, J., Grieco, A., Abate, M., Friedman, S. L., Narla, G., Bugianesi, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.004 · Cited by 196
Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-δ
Lam, T. K. T., Yoshii, H., Haber, C. A., Bogdanovic, E., Lam, L., Fantus, I. G., & Giacca, A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00038.2002 · Cited by 195
OBSERVATIONS CONCERNING THE ACTION OF 5‐HYDROXYTRYPTAMINE ON THE PERISTALTIC REFLEX
BÜLBRING, E., & CREMA, A. (1958) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1958.tb00236.x · Cited by 194
Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C
Hézode, C., Zafrani, E. S., Roudot–Thoraval, F., Costentin, C., Hessami, A., Bouvier–Alias, M., Medkour, F., Pawlostky, J., Lotersztajn, S., & Mallat, A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.039 · Cited by 190
Hensley, K. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.983 · Cited by 183
Genetics of Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease
Wilfred de Alwis, N., & Day, C. (2007) · Seminars in Liver Disease · doi:10.1055/s-2006-960170 · Cited by 181
Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
Choudhury, J., & Sanyal, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.006 · Cited by 177
Nocito, A., Dahm, F., Jochum, W., Jang, J. H., Georgiev, P., Bader, M., Renner, E. L., & Clavien, P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.019 · Cited by 175
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair
Jin, X., Zimmers, T. A., Perez, E. A., Pierce, R. H., Zhang, Z., & Koniaris, L. G. (2006) · Hepatology · doi:10.1002/hep.21087 · Cited by 173
Louet, J., Chatelain, F., Decaux, J., Park, E. A., Kohl, C., Pineau, T., Girard, J. R., & Pégorier, J. P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540189 · Cited by 167
Shimada, M., Kawahara, H., Ozaki, K., Fukura, M., Yano, H., Tsuchishima, M., Tsutsumi, M., & Takase, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01322.x · Cited by 163
Role of ChREBP in hepatic steatosis and insulin resistance
Denechaud, P.-D., Dentin, R., Girard, J., & Postic, C. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.07.084 · Cited by 163
Angiotensin II and oxidative stress
Hitomi, H., Kiyomoto, H., & Nishiyama, A. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3281532b53 · Cited by 162
Satapathy, S. K., Sakhuja, P., Malhotra, V., Sharma, B. C., & Sarin, S. K. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04756.x · Cited by 160
CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids
McAllister, S. D., & Glass, M. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0344 · Cited by 159
Cell Signaling in Oxidative Stress-Induced Liver Injury
Czaja, M. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-991514 · Cited by 158
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Larter, C. Z., & Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.030 · Cited by 155
Bugianesi, E., Marchesini, G., Gentilcore, E., et al. (2006) · Hepatology · doi:10.1002/hep.21429 · Cited by 155
Does Leptin Play A Role in The Pathogenesis of Human Nonalcoholic Steatohepatitis?
Chalasani, N., Crabb, D. W., Cummings, O. W., Kwo, P. Y., Asghar, A., Pandya, P., & Considine, R. V. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.08767.x · Cited by 151
El-Assal, O. N., Hong, F., Kim, W., Radaeva, S., & Gao, B. (2004) · PubMed · Cited by 148
Peters, J., Zhou, Y., Ram, P. A., Lee, S. S., Gonzalez, F. J., & Waxman, D. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09162-x · Cited by 144
Control by the endogenous cannabinoid system of ras oncogene‐dependent tumor growth
Bifulco, M., Laezza, C., Portella, G., Vitale, M., Orlando, P., PETROCELLIS, L. D., & Marzo, V. D. (2001) · The FASEB Journal · doi:10.1096/fj.01-0320fje · Cited by 140
Musso, G., Gambino, R., Michieli, F. D., Durazzo, M., Pagano, G., & Cassader, M. (2008) · Hepatology · doi:10.1002/hep.22142 · Cited by 137
Charlton, M., Angulo, P., Chalasani, N., Merriman, R., Viker, K., Charatcharoenwitthaya, P., Sanderson, S. O., Gawrieh, S., Krishnan, A., & Lindor, K. D. (2008) · Hepatology · doi:10.1002/hep.22063 · Cited by 136
Cheung, O., Kapoor, A., Puri, P., Sistrun, S. N., Luketic, V. A., Sargeant, C., Contos, M. J., Shiffman, M. L., Stravitz, R. T., Sterling, R. K., et al. (2007) · Hepatology · doi:10.1002/hep.21803 · Cited by 136
Edvardsson, U., Bergström, M. F., Alexandersson, M., Bamberg, K., Ljung, B., & Dahllöf, B. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33479-9 · Cited by 124
Wei, Y., Clark, S. E., Morris, E. M., Thyfault, J. P., Uptergrove, G. M., Whaley‐Connell, A. T., Ferrario, C. M., Sowers, J. R., & Ibdah, J. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.018 · Cited by 121
Tomita, K., Oike, Y., Teratani, T., Taguchi, T., Noguchi, M., Suzuki, T., Mizutani, A., Yokoyama, H., Irie, R., Sumimoto, H., et al. (2008) · Hepatology · doi:10.1002/hep.22365 · Cited by 121
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
Arsov, T., Larter, C. Z., Nolan, C. J., Petrovsky, N., Goodnow, C. C., Teoh, N., Yeh, M. M., & Farrell, G. C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.032 · Cited by 119
Effect of Dehydroepiandrosterone Replacement on Insulin Sensitivity and Lipids in Hypoadrenal Women
Dhatariya, K., Bigelow, M. L., & Nair, K. S. (2005) · Diabetes · doi:10.2337/diabetes.54.3.765 · Cited by 119
Gambino, R., Cassader, M., Pagano, G., Durazzo, M., & Musso, G. (2007) · Hepatology · doi:10.1002/hep.21631 · Cited by 118
RXR: From Partnership to Leadership in Metabolic Regulations
Desvergne, B. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)75001-4 · Cited by 116
Endocannabinoids and related fatty acid derivatives in pain modulation
Walker, J. M., Krey, J. F., Chu, C. J., & Huang, S. M. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00152-4 · Cited by 113
Balasubramanian, S., & Paulose, C. S. (1998) · Hepatology · doi:10.1002/hep.510270111 · Cited by 103
Serum retinol‐binding protein 4 levels are elevated in non‐alcoholic fatty liver disease
Seo, J. A., Kim, N. H., Park, S. Y., Kim, H. Y., Ryu, O., Lee, K. W., Lee, J., Kim, D. L., Choi, K. M., Baik, S. H., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03072.x · Cited by 100
Nobili, V., Manco, M., Ciampalini, P., Ciommo, V. M. D., Vito, R. D., Piemonte, F., Comparcola, D., Guidi, R., & Marcellini, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02288 · Cited by 94
Beraza, N., Malato, Y., Borght, S. V., Liedtke, C., Wasmuth, H. E., Dréano, M., Vos, R. D., Roskams, T., & Trautwein, C. (2008) · Gut · doi:10.1136/gut.2007.134288 · Cited by 89
Clément, S., Juge-Aubry, C. E., Sgroi, A., Conzelmann, S., Pazienza, V., Pittet-Cuenod, B. M., Meier, C. A., & Negro, F. (2008) · Hepatology · doi:10.1002/hep.22404 · Cited by 88
Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease
Méndez‐Sánchez, N., Zamora‐Valdés, D., Pichardo-Bahena, R., Barredo-Prieto, B. A., Ponciano‐Rodríguez, G., Bermejo-Martínez, L., Chávez-Tapia, N. C., González, H. A. B., & Uribe, M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01401.x · Cited by 83
Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease
Huang, X., Fan, Y., Hen, Z., Wang, P., Yuan, J.-P., Li, M., & Zhan, X.-Y. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2888 · Cited by 78
Long-Term Consequences After Jejunoileal Bypass for Morbid Obesity
Hocking, M. P., Davis, G. L., Franzini, D. A., & Woodward, E. R. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026698602714 · Cited by 76
Poníachik, J., Csendes, A., Díaz, J. C., Flores, J. R., Patricio Burdiles, P., Maluenda, F., Smok, G., Rodrigo, R., & Videla, L. A. (2006) · Cytokine · doi:10.1016/j.cyto.2006.02.006 · Cited by 75
Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans
Hertz, R., & Bar‐Tana, J. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00290-2 · Cited by 71
Scheen, A. J. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01681.x · Cited by 68
Petta, S., Cammà, C., Marco, V. D., Alessi, N., Barbaria, F., Cabibi, D., Caldarella, R., Ciminnisi, S., Licata, A., Massenti, M. F., et al. (2008) · Hepatology · doi:10.1002/hep.22316 · Cited by 61
Self-citation
Cited by
Pathogenesis of non-alcoholic fatty liver disease
Dowman, J. K., Tomlinson, J. W., & Newsome, P. N. (2010) · QJM · doi:10.1093/qjmed/hcp158 · Cited by 741
De novo lipogenesis in health and disease
Ameer, F., Scandiuzzi, L., Hasnain, S., Kalbacher, H., & Zaidi, N. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.003 · Cited by 611
Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations
Milić, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9330 · Cited by 583
Molecular pathways in non-alcoholic fatty liver disease
Auguet, T., Berlanga, A., Guiu-Jurado, E., & Porras, J. A. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s62831 · Cited by 379
Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances
Lau, J. K. C., Zhang, X., & Yu, J. (2017) · The Journal of Pathology · doi:10.1002/path.4829 · Cited by 373
“Studies have found a strong association between the degree of oxidative stress and the severity of NASH [35], and also the presence of biological markers of oxidative stress, in both patients and animal models of steatohepatitis [36,37].”
Background
Metadata
- Authors
- Petta, S., Muratore, C., & Craxì, A.
- Venue
- Digestive and Liver Disease
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 41
- Issue
- 9
- Pages
- 615-625
- ISSN
- 1590-8658 (ISSN-L)
- OpenAlex
- W1977756684
- Cited by
- 285
- References
- 207
- FWCI
- 12.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.